1. Home
  2. RDHL vs HOFV Comparison

RDHL vs HOFV Comparison

Compare RDHL & HOFV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • HOFV
  • Stock Information
  • Founded
  • RDHL 2009
  • HOFV 2015
  • Country
  • RDHL Israel
  • HOFV United States
  • Employees
  • RDHL 53
  • HOFV N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • HOFV Services-Misc. Amusement & Recreation
  • Sector
  • RDHL Health Care
  • HOFV Consumer Discretionary
  • Exchange
  • RDHL Nasdaq
  • HOFV Nasdaq
  • Market Cap
  • RDHL 6.8M
  • HOFV 8.2M
  • IPO Year
  • RDHL N/A
  • HOFV N/A
  • Fundamental
  • Price
  • RDHL $5.23
  • HOFV $1.18
  • Analyst Decision
  • RDHL
  • HOFV Hold
  • Analyst Count
  • RDHL 0
  • HOFV 1
  • Target Price
  • RDHL N/A
  • HOFV N/A
  • AVG Volume (30 Days)
  • RDHL 10.4K
  • HOFV 17.9K
  • Earning Date
  • RDHL 04-07-2025
  • HOFV 03-19-2025
  • Dividend Yield
  • RDHL N/A
  • HOFV N/A
  • EPS Growth
  • RDHL N/A
  • HOFV N/A
  • EPS
  • RDHL N/A
  • HOFV N/A
  • Revenue
  • RDHL $3,707,000.00
  • HOFV $22,529,744.00
  • Revenue This Year
  • RDHL $224.90
  • HOFV N/A
  • Revenue Next Year
  • RDHL $82.69
  • HOFV $10.19
  • P/E Ratio
  • RDHL N/A
  • HOFV N/A
  • Revenue Growth
  • RDHL N/A
  • HOFV 7.02
  • 52 Week Low
  • RDHL $5.20
  • HOFV $0.81
  • 52 Week High
  • RDHL $20.28
  • HOFV $3.78
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 31.92
  • HOFV 49.27
  • Support Level
  • RDHL $5.52
  • HOFV $1.11
  • Resistance Level
  • RDHL $5.71
  • HOFV $1.29
  • Average True Range (ATR)
  • RDHL 0.27
  • HOFV 0.10
  • MACD
  • RDHL -0.04
  • HOFV -0.01
  • Stochastic Oscillator
  • RDHL 2.38
  • HOFV 30.53

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.

About HOFV Hall of Fame Resort & Entertainment Company

Hall Of Fame Resort & Entertainment Co operates as a holding company. The firm is a sports, entertainment, and media company. It generates revenues from various streams such as sponsorship agreements, rents, cost recoveries, events, hotel operations, Hall of Fantasy League, and through the sale of media assets.

Share on Social Networks: